Humanetics Is A Privately Heldclinical Stage Pharmaceutical Company Located In The Minneapolis Metropolitan Area Our Lead Candidatebio 300 Is Being Developed For Multiple Clinical Uses With A Primary Focus On Improving Treatment Of Solid Tumor Cancersbio 300 Is Being Developed As An Agent To Both Sensitize Tumor Cells To Enhance Radiation Treatment Efficacy And To Protect Normal Tissues From Harmthusreducing Common Treatment Related Side Effects Such As Radiation Induced Pneumonitiserectile Dysfunctionmucositis And Xerostomia Bio 300 Is Also Under Development For Inflammatory Lung Diseases With An Immediate Focus On Mitigation Of Pulmonary Injury Due To Covid 19 A Recent Contract From Niaid Will Fund A Phase 2 Study On Bio 300 In Recovering Covid Patients In An Effort To Stem Progressive Long Term Lung Complicationssuch As Fibrosis Bio 300 Was Licensed From The Us Department Of Defensewhere It Was Originally Developed To Prevent Injuries Associated With Ionizing Radiation This Program Is Still Underway With A Focus On Prevention Of Acute Radiation Syndrome As Well As Lung Injury For More Information About Humaneticsplease Visit Our Corporate Website At Www Humaneticscorp Com
